Effects on urinary albumin excretion and renal function changes by delapril and manidipine in normotensive type 2 diabetic patients with microalbuminuria

Journal of the Medical Association of Thailand

Volumn 84, Issue 2, 2001, Pages 234-241

  Deerochanawong, C ^a   Phongwiratchai, S ^a   Kornthong, P ^a   Serirat, S ^a  

^a RAJAVITHI HOSPITAL   (Thailand)

Author keywords

Delapril; Manidipine; Microalbuminuria; Normotension; Type 2 Diabetes

Indexed keywords

DELAPRIL; MANIDIPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE CLEARANCE; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ADULT; AGED; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DIABETIC NEPHROPATHIES; DIHYDROPYRIDINES; HUMANS; INDANS; KIDNEY; MIDDLE AGED;

EID: 0034996082     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
2. Predicting diabetic nephropathy in insulin-dependent diabetic patients
3. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
4. Natural history of diabetic nephropathy
5. Microalbuminuria: A major risk factor in non-insulin dependent diabetes: A 10-year follow-up study of 503 patients
6. Prospective study of microalbuminuria as a predictor of mortality in NIDDM
7. Albuminuria and poor glycemic control predict mortality in NIDDM
8. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
9. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
10. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy
11. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria
12. Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbunminuria
13. Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbu-minuria or microalbuminuria
14. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria
15. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and proteinuria in normotensive type 2 diabetic patients
16. Long term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study
17. Renal function changes in microalbuminuric normotensive type 2 diabetic patients treated with angiotensin-converting enzyme inhibitors
18. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: Results of a 4-year, prospective, randomized study
19. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
20. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephopathy and normal blood pressure
21. Effect of manidipine hydrochloride on persistent microalbuminuria in normotensive diabetic patients
22. Diabetic nephropathy (Position Statement)
23. Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the scientific advisory board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation
24. Determinants of progression of microalbuminuria in patients with NIDDM: A prospective study
25. Comparison of enalapril and nifedipine in treating non-insulin-dependent diabetes associated with hypertension: One-year analysis
26. Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria
27. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients
28. Calcium channel blockers versus other anti-hypertensive therapies on progression of NIDDM associated nephropathy
29. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta regression analysis
30. The renoprotective effect of antihypertensive drugs
31. Calcium antagonists and renal disease
32. Antihypertensive agents and renal protection: Calcium channel blockers
33. Renal effects of manidipine hydrochloride: A new calcium antagonist in hypertensive patients
34. Diverse effects of calcium antagonists on glomerular hemodynamics
35. Diabetes mellitus: A disease of abnormal cellular calcium metabolism
36. Intracellular free calcium abnormalities in fibroblasts from NIDDM patients with and without arterial hypertension
37. Altered calcium handling in response to fibroblast growth factor by cultured skin fibroblasts from non-insulin-dependent diabetic patients with hypertension and microalbuminuria